2,3-bis(4-hydroxyphenyl)-propionitrile has been researched along with Lymphoma, T-Cell in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Hasni, MS; Iravani, M; Jondal, M; Nilsson, S; Okret, S; Rhönnstad, P; Yakimchuk, K | 1 |
1 other study(ies) available for 2,3-bis(4-hydroxyphenyl)-propionitrile and Lymphoma, T-Cell
Article | Year |
---|---|
Effect of ligand-activated estrogen receptor β on lymphoma growth in vitro and in vivo.
Topics: Animals; Antineoplastic Agents, Hormonal; Apoptosis; Burkitt Lymphoma; Cell Division; Cell Line, Tumor; Drug Screening Assays, Antitumor; Estradiol; Estrogen Receptor beta; Female; Humans; Liver Neoplasms, Experimental; Lymphoma, T-Cell; Male; Mice; Mice, Inbred C57BL; Neoplasm Proteins; Neoplasm Transplantation; Neoplasms, Hormone-Dependent; Nitriles; Ovariectomy; Propionates; Species Specificity; Xenograft Model Antitumor Assays | 2011 |